Clinical Trial Update: A Study to Evaluate the Safety and Efficacy of LT3001 Drug Product in Subjects AIS Undergoing EVT [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for LT3001 Drug Product in acute ischemic stroke patients undergoing endovascular therapy; trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• LT3001 Drug Product (LT3001)

Snippet

Sponsor: Lumosa Therapeutics Co., Ltd. | Conditions: Acute Ischemic Stroke | Phase 2 | Status: RECRUITING